U.S. Markets closed

Geron to Present at the Stifel Healthcare Conference

MENLO PARK, Calif., September 4, 2013 - Geron Corporation (GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 9:45 a.m. Eastern Time on Wednesday, September 11, at the Stifel Nicolaus 2013 Healthcare Conference in Boston.

A live webcast of the presentation will be available at http://www.veracast.com/webcasts/stifel/healthcare2013/69104361814.cfm. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com

###



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Geron Corp. via Thomson Reuters ONE

HUG#1727323